Behavioral sensitization to WIN55212.2 in rats pretreated with heroin

scientific article published in April 2001

Behavioral sensitization to WIN55212.2 in rats pretreated with heroin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0006-8993(01)02158-8
P698PubMed publication ID11292463

P2093author name stringF E Pontieri
F R Patacchioli
A Scontrini
F R Buttarelli
P Monnazzi
P2860cites workMesolimbic dopaminergic decline after cannabinoid withdrawalQ34750833
Neurobiology of opiate abuseQ36208827
A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouseQ39609704
Opioid and cannabinoid receptorsQ40628131
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawalQ40890918
Under siege: The brain on opiatesQ40986699
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brainQ42528679
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentQ42546895
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brainQ44342706
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanismQ44346123
Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinolQ48141521
Functional correlates of heroin sensitization in the rat brainQ48593949
Intravenous morphine increases glucose utilization in the shell of the rat nucleus accumbensQ71495985
Metabolic mapping of the effects of WIN 55212-2 intravenous administration in the ratQ73349562
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)178-180
P577publication date2001-04-01
P1433published inBrain ResearchQ4955782
P1476titleBehavioral sensitization to WIN55212.2 in rats pretreated with heroin
P478volume898

Reverse relations

cites work (P2860)
Q37164808Advances in the field of cannabinoid--opioid cross-talk
Q73578944Beta-phenylethylamines and the isoquinoline alkaloids
Q30807024Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data
Q45067725Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine
Q40687653Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
Q34575484Drug addiction.
Q38267170Electroacupuncture of 2 hz has a rewarding effect: evidence from a conditioned place preference study in rats
Q35048784Endogenous opiates and behavior: 2001.
Q46673452Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine
Q52147495Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens.
Q42519724Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum
Q36309904Microinjection of WIN55,212-2 as A Cannabinoid Agonist into The Basolateral Amygdala Induces Sensitization to Morphine in Rats
Q36259799Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence
Q46513876Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity
Q44371415Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
Q44437771WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation

Search more.